,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny,breast,4', 'breast', 'destiny-breast04']
tsg reports live from chicago #asco22: the ground-breaking destiny-breast04 trial received a standing ovation. here s what we thought about the presentation! #tsgcongresscoverage 
Dedicated to scientific strategy that creates epiphany moments with healthcare audiences